An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend
Clinical trial NCT00150319 · TERMINATED
Trial details
- NCT number
- NCT00150319
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2005-10-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.